BioStock Studio: An in-depth look at Ultimovacs' cancer vaccine

The field of immuno-oncology is growing, and cancer vaccines are a big part of that. Norwegian biotech Ultimovacs is developing its own cancer vaccine technology platform. BioStock invited Sara Mangsbo, Chief Innovation Officer at Ultimovacs, to the Studio to learn more.

Watch the interview with Sara Mangsbo at biostock.se:

https://www.biostock.se/en/2022/05/an-in-depth-look-at-ultimovacs-cancer-vaccine/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/